Sign in

CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company

Keros Therapeutics, Inc.

Sign in to watch
Ticker
KROS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
811173868
Phone
617-314-6297
Business address
1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
  1. 8-K Event Other events
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. S-1 Offering Registration Statement
  5. 10-Q Report Quarterly Report
  6. 8-K Event Results of operations · Regulation FD disclosure
  7. SC 13G Stake Amended Statement of Ownership
  8. UPLOAD Other SEC-generated Letter
  9. DRS Other Draft Registration Statement
  10. 8-K Event Agreement ended
  11. 8-K Event Other events
  12. 8-K Event Other events
  13. 8-K Event Regulation FD disclosure
  14. SC 13G Stake Amended Statement of Ownership
  15. 8-K Event Results of operations
  16. 10-Q Report Quarterly Report
  17. 8-K Event Other events
  18. 8-K Event Regulation FD disclosure
  19. 8-K Event Other events
  20. 8-K Event Regulation FD disclosure

Page 24 of 27 · 537 filings